CANCELLED - SECTION 8
section 8
on 10 Mar 2023
Last Applicant/ Owned by
983 University Ave., Building B
Los Gatos
CA
95032
Serial Number
86646852 filed on 01st Jun 2015
Registration Number
5032844 registered on 30th Aug 2016
Correspondent Address
Los Gatos CA 95032
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
AERUCIN
Pharmaceutical preparations for the treatment and prevention of pneumonia, cystic fibrosis, eye infection, bronchitis, bronchiectasis, urinary tract infections, COPD, bloodstream infection, skin infections, surgical related infections, endocarditis; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment and prevention of pneumonia, cystic fibrosis, eye infection, bronchitis, bronchiectasis, urinary tract infections, COPD, bloodstream infection, skin infections, surgical related infections, endocarditis; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
First Use Date in General
20th Jan 2016
First Use Date in Commerce
20th Jan 2016
Mark Details
Serial Number
No 86646852
Mark Type
No Service/Collective Mark
Attorney Docket Number
No T002-Aeru
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Mar 2023 | CANCELLED SEC. 8 (6-YR) |
| 30th Aug 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 14th May 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 14th May 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 14th May 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 30th Aug 2016 | REGISTERED-PRINCIPAL REGISTER |
| 26th Jul 2016 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 25th Jul 2016 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 25th Jun 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 25th Jun 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |